Lance E. Perryman

Anti-cryptosporidium parvum preparations

Washington, DC: U.S. Patent and Trademark Office.

Neutralization-sensitive epitopes of Cryptosporidium parvum

Washington, DC: U.S. Patent and Trademark Office.

Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 46(2), 275–282.

Neutralization-sensitive epitopes of Cryptosporidium parvum

Washington, DC: U.S. Patent and Trademark Office.

Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection

Journal of Eukaryotic Microbiology, (2001), 44S–46.

Anti-Cryptosporidium parvum preparations

Washington, DC: U.S. Patent and Trademark Office.

Detection of mucosally delivered antibody to Cryptosporidium parvum p23 in infected calves

In K. M. K. J. A. House & E. P. J. Gibbs (Eds.), Tropical veterinary diseases: Control and prevention in the context of the new world order (Vol. 916, pp. 378–387). New York, NY: New York Academy of Sciences.

Excretion patterns of mucosally delivered antibodies to p23 in Cryptosporidium parvum infected calves

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 76(3-4), 309–317.

Primary immunodeficiencies of horses

VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 16(1), 105-+.

Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid

Infection and Immunity, 67(3), 1317–1322.

Detection of equine antibodies to Babesia Caballi by recombinant B-Caballi Rhoptry-associated protein 1 in a competitive-Inhibition enzyme-linked immunosorbent assay

Journal of Clinical Microbiology, 37(7), 2285–2290.

Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein

VACCINE, 17(17), 2142–2149.

CD8 dimer usage on alpha beta and gamma delta T lymphocytes from equine lymphoid tissues

IMMUNOBIOLOGY, 198(4), 424–438.

Equine SCID: mechanistic analysis and comparison with murine SCID

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 65(1), 1–9.

IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: Analysis of CD4(+)alpha beta+IFN-gamma(+) and CD4(+)alpha beta+IL-4(+) lymphocytes in gut-associated lymphoid tissue during resolution of infection

Journal of Immunology, 161(4), 1891–1900.

A kinase-negative mutation of DNA-PK(CS) in equine scid results in defective coding and signal joint formation

Journal of Immunology, 158(8), 3565–3569.

Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum

Infection and Immunity, 65(1), 185–190.

Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies

VIROLOGY, 230(2), 275–280.

Evaluation of a test for identification of Arabian horses heterozygous for the severe combined immunodeficiency trait

Journal of the American Veterinary Medical Association, 211(10), 1268-.

Genetic and biochemical analysis of erythrocyte-stage surface antigens belonging to a family of highly conserved proteins of Babesia equi and Theileria species

Molecular and Biochemical Parasitology, 90(1), 69–79.

A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes

MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 80(2), 137–147.